Tech Mahindra Launches FiDaaS Solution Powered by Alveo to Address Financial Services’ Data Management Challenges
The highly scalable solution will help financial institutions meet their risk management, valuation, security master…
4 years ago
Airtel Inks Deal with Juniper Networks to Further Expand Broadband Network Coverage Across India
NEW DELHI--(BUSINESS WIRE)--Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that…
4 years ago
Visa Introduces Crypto Advisory Services to Help Partners Navigate a New Era of Money Movement
The case for crypto is getting stronger for financial institutions; new global research finds nearly…
4 years ago
Heritage Brand Yun Nam Hair Care Partners With Social Media Influencers to Promote a More Youthful Image
SINGAPORE - Media OutReach - 8 December 2021 - Well known heritage brand Yun Nam Hair Care is…
4 years ago
CR2 Continues to Drive Innovation as Cardless ATM Access Goes Live in Eight Countries
DUBLIN--(BUSINESS WIRE)--#CR2--It’s a major concern for banking customers worldwide in this time of a global…
4 years ago
APRU Metagame Conference 2021 Returns at Cyberport’s Annual Digital Entertainment Leadership Forum
HONG KONG--(BUSINESS WIRE)--#HigherEducation--In partnership with Cyberport, the 2nd Association of Pacific Rim Universities (APRU) Metagame…
4 years ago
Global plastic molding company and contract manufacturer Rosti advances 3D printing with Ultimaker
From concept to reality within 72 hours as Rosti accelerates design process workflow through 3D…
4 years ago
WhatsApp customer engagement tool WATI.io raises $10 Mn as it grows revenues 5x in just 6 months
HONG KONG SAR - News Direct - 8 December 2021 - WATI.io (WhatsApp Team Inbox), a comprehensive WhatsApp…
4 years ago
Tillotts Pharma AG announces that DIFICLIRTM (fidaxomicin) is recommended for the treatment of Clostridioides difficile infection (CDI) by ESCMID
DIFICLIRTM (fidaxomicin) is now recommended as first-line CDI treatment in both European and U.S. guidelines1,2…
4 years ago
Tillotts Pharma AG announces that DIFICLIRTM (fidaxomicin) is recommended for the treatment of Clostridioides difficile infection (CDI) by ESCMID
DIFICLIRTM (fidaxomicin) is now recommended as first-line CDI treatment in both European and U.S. guidelines1,2…
4 years ago